Background: Porcine reproductive and respiratory syndrome (PRRS) causes extensive economic losses in the swine industry. Current strategies and vaccines to control the disease are inadequate. We previously demonstrated that peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) could potently inhibit PRRS virus (PRRSV) replication in cell cultures. PPMOs are single-stranded DNA analogues containing a modified backbone and cell-penetrating peptide. PPMOs are nuclease-resistant, water-soluble, can enter cells readily and exhibit highly specific binding to complementary RNA. In this study, we examined PPMO-mediated inhibition of PRRSV replication in a primary culture of porcine pulmonary alveolar macrophages (PAMs). Methods: PAMs were collected from piglets, pre-incubated in culture and infected with PRRSV. Viability, cytopathic effects, virus yield and apoptosis of PAMs in the presence or absence of a PPMO (5UP2) were examined. The 5UP2 PPMO is complementary to a conserved sequence in the 5′-terminal region of the PRRSV genome. The level of several interferon-associated gene products and activity of caspases were monitored. Results: PRRSV infection induced the activity of caspases-3/7, -8 and -9 significantly. Treatment of PAMs with 5UP2 resulted in protection of the cells from PRRSV-induced cell death for at least 7 days and avoided the activation of the caspases evaluated. 5UP2 treatment of PRRSVinfected PAMs also prevented the vigorous induction of interferon-β and chemokines observed in infected and mock-treated PAMs. Conclusions: PPMO-mediated suppression of PRRSV replication in PAMs was associated with a reduction of apoptotic and inflammatory responses. These results provide further rationale for the development of PPMO 5UP2 as an antiviral to control PRRSV infection.
Porcine reproductive and respiratory syndrome (PRRS)
is an economically important disease, causing an estimated US $560 million loss per year to the swine industry in the USA [1] . The causative agent, PRRS virus (PRRSV), is a positive-sense RNA virus belonging to the family Arteriviridae [2] . Current management strategies and commercial live or autogenously killed vaccines have generally proven inadequate for long-term control of PRRS; hence, alternative or additional strategies for PRRS control are desirable. We previously reported potent inhibition of PRRSV replication in cell culture with peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) [3, 4] .
PPMOs are oligonucleotide analogues containing a backbone composed of morpholine rings and phosphorodiamidate linkages, and include an argininerich cell-penetrating peptide covalently conjugated at the 5′-end [5] . PPMOs are nuclease-resistant, watersoluble, can enter cells readily and act as antisense agents through steric blocking of complementary RNA. Sequence-specific antiviral activity by PPMOs has also been documented against a number of other RNA viruses (reviewed in [6] ). Notably, PPMOs administered via intranasal instillation have suppressed viral replication in the lungs and reduced disease severity in mice experimentally infected with respiratory syncytial virus [7] and influenza A virus [8, 9] .
During acute infection of pigs, PRRSV mainly infects pulmonary alveolar macrophages (PAMs) [10] . PRRSV can be propagated in vitro in a number of continuous [11] , and in primary culture of PAMs. It has been shown that PRRSV induces apoptosis in MARC-145 cells and PAMs [12] [13] [14] [15] [16] [17] . Apoptosis is considered to be an innate defence mechanism and serves to limit the extent of virus infection through the elimination of infected cells. A number of viruses (such as adenovirus and herpesvirus) attempt to inhibit apoptosis, thereby increasing the production of viral progeny [18] . Conversely, other viruses (such as HIV and influenza virus) appear to induce apoptosis, thereby confounding the immune response [19] . Members of the caspase family of cysteine proteases are key mediators in the initiation and progression of the apoptotic programme, and their activation is believed essential in virtually all forms of apoptosis [20, 21] . For PRRSV infection of PAMs, caspase-mediated apoptosis has been described [13, 17] , but the mechanics of initiator and effector caspase induction are not well understood.
In addition to inducing apoptosis, PRRSV appears able to evade the interferon (IFN)-mediated antiviral response by invoking interference with signalling pathways that normally result in the production of type-I IFN [22, 23] . Type-I IFN (IFN-α and IFN-β), acting in concert with IFN-γ, are crucial to innate immunity against viruses and play important roles in the modulation of adaptive immunity [24] . Activation of IFN signalling might lead to induction of chemokines and cytokines. Chemokines are low molecular weight molecules and comprise a pivotal component in the orchestration of an effective antiviral immune response, at least partly by inducing the recruitment of leukocytes to the site of inflammation or infection [25] .
In a previous study [4] , four antisense PPMOs designed against PRRSV RNA were found to potently inhibit PRRSV replication in CRL11171 cells in culture. Treatment with the same PPMOs also significantly reduced the titre-naive of PRRSV in primary PAM cultures. In the present study, we further examined the PPMO-mediated protection of PAMs from PRRSV-induced damage. We found that treatment of PAMs with a PPMO (5UP2) targeting the 5′-untranslated region of the viral genome greatly reduced virus production and protected the cells from virus-induced apoptosis.
Methods

Cells and viruses
Primary PAM cells were prepared from bronchoalveolar lavage of 4-to 6-week-old PRRSV-negative piglets. The preparation and subsequent culture of PAMs in RPMI 1640 were conducted as previously described [4] . The PRRSV strain, VR2385, was used to inoculate PAMs at a multiplicity of infection (MOI) of 0.05. Virus titration was conducted in CRL11171 cells in a 96-well plate and the median tissue culture infectious dose (TCID 50 ) per ml was calculated according to a method described previously [3] .
For virus inactivation, supernatant containing virus was treated in a UV crosslinker (Spectronics Corporation, Westbury, NY, USA) for two 10 min pulses. Virus inactivation was confirmed by the absence of cytopatic effects (CPE) in CRL11171 cells.
PPMOs and PPMO treatment of PAMs
PPMO synthesis, dilution and storage were conducted as previously described [4, 5] . PPMO 5UP2 was designed to complement bases 9-28 in the 5′-terminal region of the PRRSV genome. A PPMO of random sequence (CP1 [4] ) was used as a control PPMO. CP1 with fluorescein conjugated to its 3′-end (producing PPMO-fluorescein [PPMO-F]) was used for testing PPMO uptake efficiency.
PAM cells were cultured for 24 or 72 h prior to treatment. Virus inoculation and PPMO treatment of PAMs were conducted as previously described [4] . Briefly, the cells were inoculated with PRRSV strain VR2385 at a MOI of 0.05 for 2 h, after which the inoculum was removed, and the cells rinsed with RPMI 1640 medium and then incubated with 16 µM PPMO 5UP2 for 4 h. After the treatment period, the PPMO solution was removed and the cells were rinsed and incubated for indicated periods of time before further evaluation.
Caspase detection and cell viability assay
The assays for caspase-3 and -7 activity were performed with Caspase-Glo 3/7 (a single kit detecting the activity of both caspases concurrently), and caspase-8 and -9 were evaluated with Caspase-Glo 8 and Caspase-Glo 9 Assay Systems (Promega, Madison, WI, USA) according to the manufacturer's instructions. Briefly, PAM cells were cultured in 96-well plates for 24 or 72 h prior to virus inoculation. At 24 h post-virus inoculation, Caspase-Glo reagent was added to the cells at a 1:1 ratio and the luminescence signal was then detected with a VICTOR3 TM Multilabel Counter (Perkin-Elmer Life and Analytical Sciences, Wellesley, MA, USA).
PAM cell viability was determined with CellTiter-Glo Cell Viability Assay (Promega). Briefly, CellTiter-Glo reagent was added to cells and the luminescence signal was measured. Relative percentages of luminescence intensity were calculated by comparison to controls.
RNA isolation and real-time reverse transcriptase-PCR
Total RNA was isolated from PRRSV-infected PAMs by TRIzol ® Reagent (Invitrogen, Carlsbad, CA, USA) as previously described [4] .
Real-time PCR primers are listed in Supplementary  Table 1 found in Additional file 1. Real-time reverse transcriptase (RT)-PCR was conducted as previously described [4] . Transcripts of ribosomal protein L32 (RPL32) were also amplified from the same samples and used to normalize for the total amount of input RNA. Relative transcript levels in PRRSV-infected PAMs were quantified by the 2 -∆∆CT method [26] and shown as relative fold of change in comparison with mock-infected and mock-treated control.
Statistical analyses
The significance of differences of viral yield, caspase activity or RNA level between the groups of PPMOtreated cells were assessed using Student's t-test. A twotailed P-value of <0.05 was considered significant.
Results
PPMO 5UP2 mediates the protection of PAMs from PRRSV-induced cell death
In our earlier study [4] , we found that 16 µM 5UP2 treatment of CRL11171 cells reduced PRRSV replication to a level that was undetectable by virus titration. A similar treatment of primary PAM cells reduced virus yield by 99%. The virus yield that remained in PAMs corresponded to 2.5 log 10 TCID 50 /ml. Here, we first investigated whether a single PPMO treatment could protect PAMs (for an extended period of time) from suffering the deleterious effects generated by the low but detectable level of virus. Primary PAM cells were infected with PRRSV, treated with PPMO 5UP2 and then incubated for 1 week. PPMO CP1 was included as a control for any generic off-target effects associated with PPMO compounds. Daily observation revealed that 5UP2-treated PAMs appeared nearly identical to that of the mock-treated and mockinfected controls, and no CPE was observed throughout the 7-day period ( Figure 1A ). To determine virus yield, culture supernatants were collected at 24 h post-infection (hpi). The titration results showed that the virus yield from 5UP2-treated PAMs was 2.5 log 10 TCID 50 /ml, whereas the virus yield of CP1-treated PAMs was similar to that of the mock-treated control ( Figure 1B) .
To further examine the 5UP2 inhibition of PRRSV replication in PAMs, culture supernatants were collected daily for 7 days and titrated for TCID 50. Because CP1 treatment did not affect virus yield in the experiment described above or in previous experiments of a similar nature [4] , it was not included in this experiment. The results for the 5UP2-treated and PRRSV-infected samples show that the virus yields averaged 2.5 log 10 TCID 50 /ml for the first 3 days after inoculation, 1.5 log 10 TCID 50 / ml at 4 days post-infection (dpi) and was undetectable from 5 to 7 dpi ( Figure 1C ). By contrast, virus yields in the mock-treated control averaged 4.5 log 10 TCID 50 /ml at 1 dpi and 3 log 10 TCID 50 /ml at 7 dpi, although most of the cells had died by day 2 post-infection.
Because no CPE was observed for 7 days in the above experiment, it appeared that the low virus yield still present in PAMs after 5UP2 treatment did not affect cellular health. To further verify this observation, we conducted cell viability assays. The results showed that PRRSV-infected and 5UP2-treated PAMs remained >80% viable compared with the mock-infected and mock-treated PAM control ( Figure 1D ).
As the 5UP2-treated PAMs appeared normal and were viable after PRRSV infection, we tested whether the PPMO could protect these cells against reinfection from a fresh inoculum of the virus. The cells were inoculated with PRRSV and treated with 5UP2 for 4 h on day 1, and then reinoculated with fresh PRRSV inoculum on day 4. Daily observation revealed no CPE in the 5UP2-treated cells before or after reinoculation. Culture supernatants were harvested on days 4 and 7 for virus yield titration. Virus titration of the day 7 culture supernatant showed no detectable virus ( Figure 1E ), confirming that 5UP2-treated cells were resistant to reinfection. These results indicate that the morpholino oligomer was stable inside the cells and retained its ability to act as an antiviral for at least 4 days.
PPMO uptake efficiency in PAM cells
Because 5UP2 treatment resulted in a low detectable virus yield in PAMs, compared with an undetectable yield in a similarly treated continuous cell line, we sought to investigate if differential PPMO uptake efficiency between the two cell types was contributing to the different yields. We evaluated the efficiency of PPMO uptake by PAM and by CRL11171 cells under our culture conditions. It has been reported that in order for PAMs to support efficient PRRSV replication, the cells must first undergo a pre-incubation to allow adaptation to laboratory culture conditions [27] . The PAMs were therefore first incubated for 24 or 72 h prior to a 4 h incubation with 16 µM PPMO-F. In PAMs that had undergone 24 h pre-incubation, fluorescence microscopy showed that approximately 25% and 80% of cells had green fluorescence at 4 and 24 h, respectively, after the PPMO-F treatment period (Figure 2 ). By contrast, >95% of CRL11171 cells clearly displayed PPMO uptake at both 4 and 24 h after PPMO-F treatment (data not shown). In PAMs that had received a 72 h pre-incubation, >95% of the cells were fluorescence-positive at both 4 and 24 h after PPMO-F treatment. This result indicated that a 72 h pre-incubation contributed to PAM adaptation to laboratory culture and to PPMO uptake efficiency.
The rate of PRRSV replication in PAMs is robust and the virus completes its first replication cycle , whereas an initial replication cycle appears to require >24 h in a continuous cell line (data not shown). We assumed that the more rapid PRRSV replication and the lower PPMO uptake efficiency in PAMs, compared with CRL11171 cells, together contributed to the difference in virus yield between the two cell types.
PPMO 5UP2 treatment correlates with lower levels of caspase activity in PRRSV-infected PAMs
To further investigate the mechanism of 5UP2-mediated protection from PRRSV-induced cell death, we explored the relationship between 5UP2 treatment and reduced apoptosis in PRRSV-infected PAM cells. Caspases play key roles in apoptosis by cleaving specific substrates to activate downstream elements. First, we examined caspase activities in PAMs after PRRSV infection. PAM cells were inoculated with PRRSV or mock-inoculated and tested for caspase-3/7 activity at 24 hpi. In PRRSV-infected PAMs, the activity of caspase-3/7 was increased by 4.7-fold over that of mockinoculated PAMs ( Figure 3A ). To confirm that the increase of caspase-3/7 activity was caused by active viral replication, PAMs were also inoculated with UV-inactivated PRRSV. No difference in caspase-3/7 activity was detected between PAMs receiving mock inoculum and UV-inactivated PRRSV ( Figure 3A) . The results indicate that active PRRSV replication induced an increase of caspase-3/7 activity.
The observation that active virus replication in PAMs caused an increase in caspase activation led us to investigate whether the relationship was doseresponsive. The results show that an incremental increase in PRRSV MOI from 0.01 to 0.5 caused concomitant increase in caspase-3/7 activity ( Figure  3B ). In this experiment, the effect of the culturing preincubation time of PAM on the caspase-3/7 activity was also explored. In PAMs receiving 72 h pre-incubation, PRRSV infection led to higher activity of caspase-3/7 than PAMs receiving 24 h pre-incubation. Because caspase-3/7 are effector caspases, increases of their activities indicate that upstream initiator caspases are being activated by PRRSV infection. We also examined the activities of caspase-8 and -9, which are representative indicators of extrinsic and intrinsic upstream apoptosis pathways, respectively, in PAMs receiving 24 h preincubation. Results showed that PRRSV infection led to an increase of caspase-8 and -9 activities by 12-and 8.7-fold, respectively, when measured at 24 hpi, but produced no change at 4 and 8 hpi in comparison with mock-infected PAMs ( Figure 3C and 3D) .
The above results demonstrated that PRRSV replication led to an increase in caspase activities. We speculated that the levels of caspase activities in PRRSV-inoculated PAMs receiving 5UP2 treatment would be lower than in infected controls. Compared with infected and mock-treated controls, 5UP2-treated and PRRSV-infected PAMs that received 24 h and 72 h pre-incubation had 4.81-and 4.82-fold lower levels of caspase-3/7 activity, respectively ( Figure 4A ). The PRRSV-infected PAMs receiving CP1 treatment had caspase-3/7 activity similar to that in infected PAMs receiving mock-treatment. Next, PAMs receiving a 24 h pre-incubation were infected with PRRSV, then mockor 16 µM 5UP2-treated, and the activities of caspase-8 and -9 examined at 24 hpi. The results show that PAMs receiving 5UP2 treatment had 2.4-and 2.2-fold reductions in caspase-8 and -9 activities, respectively, compared with infected controls (Figure 4B and 4C) . The PRRSV-infected PAMs receiving CP1 treatment had activities of caspase-8 and -9 similar to that of infected PAMs receiving mock-treatment. Uninfected PAMs receiving mock, 5UP2 or CP1 treatment all yielded similar levels of caspase-3/7, -8 and -9 activity, indicating that PPMO treatment did not generically activate these caspases. All the above differences in levels of caspase activities between 5UP2 and a corresponding control sample achieved statistical significance (Figure 4) . Because 5UP2 treatment protected PAMs from PRRSV-induced cell death for at least 7 days (Figure 1 ), we also examined the level of caspase-3/7 activity in PAMs at 7 dpi. PRRSV-infected and 5UP2-treated PAMs 
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had no increase in caspase-3/7 activity compared with mock-infected and mock-treated PAMs. This result is consistent with the cell viability assay (Figure 1C ) that demonstrated a high percentage of viability for PRRSVinfected and 5UP2-treated PAMs at 7 dpi.
PPMO 5UP2 treatment correlates with reduced IFNassociated gene expression in PRRSV-infected PAMs
On the basis of the above observations and reports that PRRSV interferes with the IFN-mediated antiviral response [22, 23] , we postulated that 5UP2-mediated inhibition of PRRSV replication might be associated with a cellular antiviral response. To investigate this speculation, we selected a group of cellular gene products known to be involved in IFN signalling and related pathways, and conducted quantitative RT-PCR to assess their expression in infected PAMs in the presence or absence of 5UP2 treatment. Because CP1 treatment did not affect the titres or caspase activities of infected PAMs in the above experiments, it was not included in this experiment. Compared with mock-infected controls, the expression of CXCL10, IFN-β and CCL2 in PRRSV-infected PAMs were 2,157-, 1,740-and 108-fold higher, respectively, the largest increases among the various transcripts evaluated (Figure 5) . The expression of double-stranded RNA-activated protein kinase R (PKR), IFN regulatory factor-1 (IRF-1), signal transducers and activators of transcription-1 (STAT-1), tumour necrosis factor-α (TNF-α), Toll-like A B C receptor-3 (TLR-3) and nuclear factor-κB p65 (NF-κB) in infected PAMs were 7.5-, 6.4-, 6.4-, 8.3-, 2.8-and 1.7-fold higher, respectively ( Figure 5 ). Little change in the expression of p38 mitogen-activated protein kinase and IRF-3 was detected in infected PAM cells. 5UP2 treatment of PRRSV-infected PAMs resulted in 55-and 7-fold lower levels of IFN-β and TNF-α expression, respectively, compared with infected and mocktreated control samples (P<0.01). Likewise, the expression of CXCL10, CCL2, IRF-1, PKR, STAT-1, TLR-3 and NF-κB in the 5UP2-treated cells were also lower by 47-, 17-, 4.6-, 2.8-, 2.7-, 1.9-and 1.6-fold, respectively (P<0.05; Figure 5 ). TNF-α is known to be an inducer of apoptosis [28] . The lower level of TNF-α found in the 5UP2-treated PAMs is consistent with the caspase activation detection results above. Our data indicate that 5UP2-mediated inhibition of PRRSV replication in PAMs is associated with a reduction in the expression level of certain cellular gene products, such as CXCL10 and CCL2, which are thought to play roles in the inflammatory response by eliciting stress response and ultimately cell death. A reduction in proteins associated with the inflammatory response might have contributed to the 5UP2-mediated protection of PAMs from PRRSV-induced cell death.
Discussion
In this study, we examined mechanistic correlates of the PPMO-mediated protection of PAMs from PRRSVinduced cell death. Treatment of the cells with PPMO 5UP2 inhibited PRRSV replication and resulted in lower levels of inflammation-and apoptotic-associated gene expression than those observed in infected control samples. The cells were protected from PRRSV-induced cell death for at least 7 days.
We observed a small amount of virus in PRRSVinfected and 5UP2-treated PAMs, whereas we previously found that 5UP2 treatment completely prevented detectable viral RNA in CRL11171 cells [4] . The presence of detectable virus in PRRSV-infected and 5UP2-treated PAMs indicates that some infecting viral RNA was able to escape, duplexing with PPMO and serving as template for replication. One possible reason is that the mechanism of PRRSV replication is likely to be different in primary PAM culture than in a continuous cell line. It was found that extracellular virus titres were higher than intracellular virus titres in PAMs, but lower than or equal to intracellular virus titres in MARC-145 cells [13] .
Previous reports have suggested that PPMOs targeting the 5′-terminal region of the arterivirus genome are likely effective through interference with translation of viral RNA [3, 29] . The backbone component of PPMO has been shown to remain functionally stable inside cells for several days [30] . In this study, 5UP2-treated PAMs were not only protected from PRRSV-induced cell death, but were also resistant to PRRSV reinfection. We speculate that the presence of residual PMO inside the cells at the time of the second infection might have contributed to the prevention of virus replication. It was previously shown that pre-incubation of primary PAMs in culture for 2-3 days increased the susceptibility of the cells to PRRSV infection [27] compared with shorter pre-incubation times. Likewise, our PPMO uptake assay showed that PAMs that had received a 72 h pre-incubation were more susceptible to PPMO-F entry than those receiving a 24 h pre-incubation. These two observations indicate that PAMs might become more permissive to endocytic events with time in culture, and that PAMs receiving 72 h pre-incubation might produce higher expression of cell surface molecules, which have a role in virus and PPMO entry, than PAMs receiving only 24 h preincubation. For most of our experiments, we employed a 24 h pre-incubation because primary PAMs have a limited lifespan in culture and we wished to approximate in vivo conditions as closely as we could.
Caspases play essential roles in apoptosis. Numerous studies have demonstrated that viruses induce apoptosis via extrinsic and/or intrinsic pathways. For example, HIV induces apoptosis via a caspase-8-mediated extrinsic pathway [31] , and vesicular stomatitis virus induces apoptosis via a caspase-9-mediated intrinsic pathway [32] . Crosstalk between the extrinsic and intrinsic pathways has been demonstrated in PRRSV infection of MARC-145 cells [15] . Our study indicates that the activation of caspase-3/7, -8 and -9 was the direct result of PRRSV replication in PAMs. The 5UP2 treatment of infected PAMs reduced viral replication and, as a result, prevented caspase activation. It was recently reported that PRRSV infection of PAMs leads to apoptosis after 12 hpi [13] . Our data are consistent with that report in that the activation of caspase-3/7, -8 and -9 in PRRSV-infected PAMs was significantly increased at 24 hpi. The activation of caspase 3/7 was higher in PAMs receiving 72 h pre-incubation than in those receiving 24 h pre-incubation, which might be because the former are more susceptible to PRRSV infection than the latter.
In this study, the levels of caspase activity in PRRSVinfected PAMs without PPMO treatment in the experiments of Figure 4A , 4B and 4C were somewhat lower than those in the experiments of Figure 3 . The reason for the observed difference is likely that more procedures were performed on the cells before and after mock treatment, such as changing medium and rinsing, during the experiments of Figure 4 than during those of Figure 3 . We assume that these additional manipulations caused detachment of PAMs from the surface of their culture plates, leading to a reduction in the total number of cells and thus in the levels of caspase activity measured.
Macrophages are key sentinel cells in the respiratory system and the primary target cells for PRRSV infection in vivo. Our data showed that PRRSV infection of PAMs lead to a significant increase of gene products, such as CXCL10, CCL2 and TNF-α, and that 5UP2 treatment was associated with a significant reduction in the expression of these immune-modulators. Macrophages are known to be a major source of a variety of soluble immune mediators, including cytokines and chemokines [33] [34] [35] . The chemokines CXCL10/IP-10 and CCL2/MCP-1 are chemotactic factors for monocytes/macrophages [36] , the predominant inflammatory cell types found in the lungs of pigs after PRRSV infection [37] . It will be of interest to test the level of these chemotactic factors in the blood of pigs during the early stage of PRRSV infection. Severe acute respiratory syndrome (SARS)-coronavirus, which belongs to the same order (Nidovirales) as PRRSV, infects macrophages and induces the expression of CXCL10 and CCL2 but not IFN-β [38] . In SARS patients, an increase in the level of these chemokines during the early stage of infection is thought to contribute to the development of disease. PRRSV induces the expression of these chemokines and IFN-β, indicating that PRRSV and SARS-coronavirus differ in the cellular responses that they invoke. Proinflammatory cytokines, such as TNF-α, can be important mediators of viral respiratory diseases in pigs [39, 40] . It is uncertain whether the relative transcript levels that we detected from PRRSV infection of PAMs in vitro will be consistent with protein levels of the same genes during PRRSV infection in vivo.
The results depicted in Figure 5 show the relative expression level of selected cellular genes in PRRSVinfected PAMs that received 5UP2 or mock treatment. 5UP2 treatment itself apparently had little effect on gene expression in uninfected PAMs. In a separate experiment, PRRSV-infected PAMs receiving CP1 treatment had gene expression levels similar to infected PAMs receiving mock treatment (data not shown). The minimal effect of 5UP2 or CP1 PPMO treatment on caspase activity level (Figure 4) is consistent with our earlier study showing that 5UP2 PPMO had little effect on cell viability and can produce highly specific inhibition of PRRSV replication [4] .
In summary, PRRSV induces caspase-dependant apoptosis in PAMs by both extrinsic and intrinsic pathways. Treatment of PAMs with PPMO 5UP2 inhibited PRRSV replication and protected the cells from PRRSVinduced cell death. 5UP2 treatment also resulted in reduced expression of inflammatory cytokines and chemokines in PAMs during PRRSV infection. Exploration of PPMO 5UP2 in a host animal experimental system is warranted. this study. This project was supported by a grant from the National Pork Board.
